Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The results showed that these patients achieved an average total body loss of weight of 5.9% at 3 months and 10.9% at 6 months
Because GLP-1 medications reduce appetite and food intake, prioritizing protein is essential, not optional
Off-Label Use on the Rise Despite the promising data, many of these potential benefits fall outside the current FDA-approved uses, which include obesity, Type 2 diabetes, cardiovascular risk reduction, and more recently sleep apnea in some cases
Retatrutide is showing even greater weight loss than Zepbound (tirzepatide) in trials, signaling the next wave of GLP-1 innovation
Our guide to building a high-protein plate when appetite is low explores practical strategies
US$ 25.33
US$ 27.81
US$ 21.60
